---
annotation-target: bloodbld2022016535c.pdf

---


>%%
>```annotation-json
>{"created":"2022-08-08T07:05:54.645Z","updated":"2022-08-08T07:05:54.645Z","document":{"title":"bloodBLD2022016535C.pdf","link":[{"href":"urn:x-pdf:8fb4fd9482f5fcea839cc15c5a27fd11"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/bloodbld2022016535c.pdf"}],"documentFingerprint":"8fb4fd9482f5fcea839cc15c5a27fd11"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/bloodbld2022016535c.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/bloodbld2022016535c.pdf","selector":[{"type":"TextPositionSelector","start":2965,"end":3223},{"type":"TextQuoteSelector","exact":"In this issue of Blood, Shanafelt et al1 confirm the continued superiority ofibrutinib plus rituximab (IR), compared with the prior standard treatment,fludarabine, cyclophosphamide, and rituximab (FCR), for fit patients withchronic lymphocytic leukemia (CLL)","prefix":"ichhorst | University of Cologne","suffix":". In addition, they report relev"}]}]}
>```
>%%
>*%%PREFIX%%ichhorst | University of Cologne%%HIGHLIGHT%% ==In this issue of Blood, Shanafelt et al1 confirm the continued superiority ofibrutinib plus rituximab (IR), compared with the prior standard treatment,fludarabine, cyclophosphamide, and rituximab (FCR), for fit patients withchronic lymphocytic leukemia (CLL)== %%POSTFIX%%. In addition, they report relev*
>%%LINK%%[[#^76c1qeyxuab|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^76c1qeyxuab


>%%
>```annotation-json
>{"created":"2022-08-08T07:06:11.119Z","text":"苯达莫司汀","updated":"2022-08-08T07:06:11.119Z","document":{"title":"bloodBLD2022016535C.pdf","link":[{"href":"urn:x-pdf:8fb4fd9482f5fcea839cc15c5a27fd11"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/bloodbld2022016535c.pdf"}],"documentFingerprint":"8fb4fd9482f5fcea839cc15c5a27fd11"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/bloodbld2022016535c.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/bloodbld2022016535c.pdf","selector":[{"type":"TextPositionSelector","start":3805,"end":3835},{"type":"TextQuoteSelector","exact":"chlorambucil or benda-mustine,","prefix":"hemotherapy back-bones, such as ","suffix":" did not show similar long-lasti"}]}]}
>```
>%%
>*%%PREFIX%%hemotherapy back-bones, such as%%HIGHLIGHT%% ==chlorambucil or benda-mustine,== %%POSTFIX%%did not show similar long-lasti*
>%%LINK%%[[#^5rz3cqt1qk7|show annotation]]
>%%COMMENT%%
>苯达莫司汀
>%%TAGS%%
>
^5rz3cqt1qk7
